AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

AEVIS VICTORIA SA

Investor Presentation Sep 30, 2013

808_ip_2013-09-30_2156aea1-991e-465d-9e04-f8cfe3d54aeb.pdf

Investor Presentation

Open in Viewer

Opens in native device viewer

Company presentation

October2013

Company overview

AEVIS Holding SA (AEVIS) invests in the healthcare sector, in life sciences and in services topeople

The mainshareholdings of AEVIS are:

  • Genolier Swiss Medical Network SA (GSMN), the 2nd largest group of private clinics in Switzerlandwith geographical presence in the three main language regions of Switzerland
  • Swiss Healthcare Properties AG (SHP), a real estate company focusing on medical real estate inSwitzerland
  • Other investments, supporting and complementary services along the value chain of AEVIS'strategic focus
  • AEVISpursues a dividend growth strategy
  • Start of the diversification phase in our choosen field : LIFE
  • • AEVIS wishes to progressively develop new sectors of activity, amongst others in the sector of outpatient medicine (surgical, radiology and dental centres), patient hotels (Les Hauts de Genolier) andhotel or hotel‐related activities
  • AEVIS is listedon the Domestic Standard of the SIX Swiss Exchange (Ticker: AEVS)

TheSwiss healthcare market

d
L
a
r
g
e
a
n
i
g
r
o
n
g
w
k
t
m
a
r
e
l
d
h
h
d
h
h
h
l
b
d
h
l
d
S
i
i
i
i
t
t
t
t
t

w
z
e
r
a
n
a
s
e
s
e
c
o
n
g
e
s
o
s
p
a
e
c
o
v
e
r
a
g
e
n
e
w
o
r
h
h
l
h
l
l
l
l
b
l
d
d
h
i
i
i
T
S
t
t

e
w
s
s
e
a
c
a
r
e
s
y
s
e
m
s
e
c
o
n
o
m
c
a
y
w
e
a
a
n
c
e
a
n
a
s
b
l
i
t
t
s
u
s
a
n
a
r
e
s
e
r
v
e
s
h
l
h
b
f
l
d
S
i
i
C
H
F
6
0
1
1
%
S
i
G
D
P
t
t
t

>
s
s
e
a
c
a
r
e
s
p
e
n
n
g
n
o
r
o
o
a
s
s
w
w
k
h
f
C
3
5
%
4
0
%
i
1
9
9
6
t
t
t
t
t

o
n
s
a
n
m
a
r
e
g
r
o
o
o
p
a
s
n
c
e
w
h
G
t
r
o
w
t
p
a
r
a
m
e
e
r
s
h
l
h
d
d
l
d
D
i
i
i
i
i
i
i
t
t

e
m
o
g
r
a
p
c
e
v
o
u
o
n
n
c
r
e
a
s
e
s
o
r
o
p
a
e
c
a
n
o
n
c
o
o
g
c
n
c
e
n
c
e
h
f
h
l
h
l
l‐
b
d
d
d
d
P
i
i
i
i
t
t
t

r
o
s
p
e
r
r
e
s
e
e
m
a
n
o
r
e
a
c
a
r
e
a
n
e
e
n
g
s
e
r
c
e
s
y
v
w
v
f
d
h
l
h
d
l
l‐
b
h
l
D
i
i
i
i
t
t
t

e
m
a
n
o
r
e
a
c
a
r
e
a
n
e
e
n
g
s
e
r
c
e
s
a
s
p
r
o
e
n
r
e
s
e
n
o
w
v
v
l
d
h
i
i
i
i
i
i
t
e
c
o
n
o
m
c
c
y
c
e
s
u
r
n
g
e
o
n
g
o
n
g
e
c
o
n
o
m
c
c
r
s
s
b
k
h
d
h
f
i
i
A
t
t
t
t
t
t
t
t

o
v
e
a
v
e
r
a
g
e
m
a
r
e
g
r
o
w
r
a
e
s
a
r
e
e
x
p
e
c
e
o
p
e
r
s
s
n
e
u
u
r
e
k
M
t
a
r
e
t
t
s
r
c
r
e
u
u
f
l
d
d
d
h
l
d
k
l
d
d
h
S
i
i
i
i
i
t
t
t
t

e
r
a
n
s
r
e
g
a
r
e
a
s
o
n
e
o
e
e
a
n
g
m
a
r
e
s
o
r
e
w
z
w
w
w
d
l
f
h
l
h
i
i
t
t
t
r
e
g
a
r
s
o
q
a
o
e
a
c
a
r
e
s
e
r
c
e
s
u
y
v
f
l
h
l
d
l
2
%
S
i
i
i
i
i
i
A
5
t
t
t
t
t

p
p
r
o
x
o
o
a
w
s
s
o
s
p
a
r
e
v
e
n
u
e
s
a
r
e
g
e
n
e
r
a
e
n
p
r
v
a
e
c
n
c
s
h
l
k
f
d
d
l
d
i
i
i
i
i
i
i
i
T
t
t
t
t

e
p
r
v
a
e
c
n
c
s
m
a
r
e
s
v
e
r
y
r
a
g
m
e
n
e
a
n
c
o
n
s
o
a
o
n
s
n
p
r
o
c
e
s
s
f
f
h
l
h
(
)
i
i
i
A
1
J
2
0
1
2,
S
H
I
A
K
V
G
t
t
t

s
o
a
n
u
a
r
y
a
r
e
v
s
o
n
o
e
w
s
s
e
a
n
s
u
r
a
n
c
e
c
w
a
s
d
d
l
d
h
f
f
b
d
l
l
i
i
i
i
i
i
i
t
t
t
t
n
r
o
u
c
e
m
p
y
n
g
a
p
a
r
a
g
m
s
r
o
m
e
c
a
p
a
c
y
o
s
u
p
p
y
p
a
n
n
n
g
d
d
f
l
l
d
R
i
i
i
i
i
i
i
t
t
t
t
t
t

e
v
s
o
n
s
e
x
p
e
c
e
o
n
c
r
e
a
s
e
c
o
m
p
e
o
n
a
n
n
a
y
o
r
e
u
c
e
c
o
s
s.
f
f
f
f
d
l
l
d
b
h
d
E
i
i
i
i
i
i
i
t
t
t
t
t
t
c
e
n
a
n
m
a
n
a
g
e
r
a
c
n
c
s
a
r
e
e
p
e
c
e
o
e
n
e
r
o
m
s
r
e
n
x

Group structure

AEVISHolding SA

Investments inhealthcare sector, life sciences and services to people

l
i
i
d
i
l
G
S
M
e
n
o
e
r
w
s
s
e
c
a
k
S
A
N
t
e
o
r
w
i
l
h
S
H
t
w
s
s
e
a
c
a
r
e
i
A
G
P
t
r
o
p
e
r
e
s
h
i
i
i
O
A
t
t
t
e
r
c
v
e
s
l
C
i
i
i
t
n
c
o
p
e
r
a
o
n
s
l
h
l
H
t
t
t
e
a
c
a
r
e
r
e
a
e
s
a
e
l
d
R
t
t
e
a
e
s
e
c
o
r
s
d
l
f
2
i
n
t
t

a
r
g
e
s
g
r
o
u
p
o
p
r
v
a
e
l
l
d
i
i
i
i
S
t
c
n
c
s
n
w
z
e
r
a
n
h,
i
P
F
G
t

r
e
s
e
n
n
r
e
n
c
e
r
m
a
n
d
l
k
I
i
i
t
t
a
n
a
a
n
s
p
e
a
n
g
p
a
r
s
f
l
d
S
i
t
o
w
e
r
a
n
z
l
d
1
4
i
i
i
t

n
o
p
e
r
a
o
n
s
a
n
c
c
f
f
l
d
l
1
i
i
i
i
t
a
a
e
c
n
c
h
l
h
2
i
5
t
t

e
a
a
r
e
p
r
o
p
e
r
e
s
c
2
b
l
f
'0
0
0
R
1
1
1
t

e
n
a
e
a
r
e
a
o
m
l
l
f
i
D
t
t
t

e
v
e
o
p
m
e
n
p
o
e
n
a
o
2
2
'0
'0
1
0
0
0
1
5
0
0
t
m
o
m
l
l
l
(
)
%
F
i
i
i
0
t
t

u
u
s
a
o
n
v
a
c
a
n
c
y
f
f
l
l
P
i
t

o
r
o
o
a
e
o
v
u
C
H
6
0
6
F
5
m
N

e
s
e
n
s
c
b
l
A
S
A
S
i

m
a
n
c
e
s
e
r
c
e
s
u
v
d
d
S
i
A
V
i
i

s
s
a
n
c
e
s
o
n
w
v
:
h
l
l
O
i
t
p
a
m
o
o
g
e
h
l
P
i
t
t
t

a
e
n
o
e
h
O
t

e
r
l
d
i
N
t
a
o
n
a
c
o
v
e
r
a
g
e
a
n
l
i
r
e
g
o
n
a
p
r
e
s
e
n
c
e
i
L
t
t
t
t
o
n
g
e
r
m
c
o
m
m
m
e
n
o

l
's
h
i
i
i
t
t
c
n
c
o
p
e
r
a
o
n
g
r
o
w
l
C
t
o
m
p
e
m
e
n
a
r
y
d
l
t
e
v
e
o
p
m
e
n
s

AEVIS oncapital markets

  • AEVIS is listed on the Domestic Standard of SIX Swiss Exchange (Ticker: AEVS), with a marketcapitalisation of around CHF 440m
  • In 2012, AEVIS has paid out CHF 0.30 per share to its shareholders. AEVIS plans to gradually increase the pay‐out ratio and pursues a dividend growth strategy
  • To diversify its financing sources, AEVIS has issued two straight bonds in 2012 and 2013 (CHF 80m at 4.25% maturing in 2016 and CHF 100m at 3.50% maturing in 2018)

Corporate governance – AEVIS Holding SA

Boardof directors

  • Dr. ChristianWenger, Chairman
  • Raymond Loretan, Vice‐chairman
  • AntoineHubert, Delegate of the Board
  • MichelReybier
  • AntoineKohler
  • Dr. Cédric A.George

The board of directors of AEVIS combines financial, legal and political skills as well as in‐depth knowledge of the Swiss healthcaresector

Management

  • AntoineHubert, Delegate of the Board
  • GillesFrachon, CFO
  • RobertoTancredi, Deputy CFO
  • Séverine Vander Schueren, CAO
  • Pierre‐OlivierHaenni, Managing Director

Together, the board of directors and management of AEVIS cover the necessary skill set to address the challenges of AEVIS' scope of business

Corporate governance – Genolier Swiss Medical Network SA

Boardof directors

  • Raymond Loretan, Chairman
  • Dr. Philippe Glasson, Vice‐chairman
  • AntoineHubert, Delegate of the Board
  • MichelReybier
  • AntoineKohler
  • Dr. Cédric A.George
  • Dr. ChristianLe Dorze
  • Fulvio Pelli

Management

  • AntoineHubert, Delegate of the Board
  • BeatRöthlisberger, CEO
  • Valérie Dubois‐Héquet, General Manager
  • NelloCastelli, Secretary General
  • Christophe Graziani, CFO
  • Romain Boichat, Jérôme Puginier, Florian Hässig and Babs Siclet

Together, the board of directors and the experienced management team of GSMN ensure an optimal development of AEVIS' mainparticipation

Corporate governance – Swiss Healthcare Properties AG

Boardof directors

  • AntoineHubert, Chairman
  • MichelReybier, Vice‐chairman
  • GillesFrachon
  • Christoph Syz

The board of directors of SHP is well aligned within the corporate governance of AEVIS and shares in‐depth knowledge of theportfolio of healthcare real estate

Management

  • PatrimoniumHealthcare Property Advisors AG, Baar/ZG
  • Christoph Syz, CEO
  • VivianMoreau, Portfolio Manager

GSMNand SHP – portfolio overview

l
d
b
i
i
C
G
S
M
N
n
c
s
o
w
n
e
y
l
b
l
i
A
v
a
a
e
d
i
i
A
t
t
m
n
g
l
E
m
p
o
y
e
e
s
h
f
i
O
w
n
e
r
s
p
o
b
d
e
s
h
i
i
p
s
c
a
n
s
y
l
t
t
r
e
a
e
s
a
e
l
i
i
d
l
i
C
G
n
q
u
e
e
e
n
o
e
r
1
1
5
1
7
7
2
9
0
S
H
P
i
k
l
i
i
k
h
i
P
B
t
t
r
a
n
e
a
n
e
n
v
9
6
2
2
3
2
5
0
S
H
P
l
d
i
i
i
C
A
M
n
c
a
r
s
e
c
a
7
5
3
0
1
8
0
S
H
P
'A
l
i
i
C
S
t
n
c
a
a
n
n
n
a
8
0
9
0
2
2
0
S
H
P
l
i
i
é
é
l
C
G
n
q
e
n
r
a
e
u
6
0
8
0
1
5
3
S
H
P
l
d
h
C
i
i
i
i
M
t
n
q
u
e
e
o
n
c
o
s
2
1
9
8
7
4
S
H
P
l
i
i
l
C
V
t
n
q
u
e
a
m
o
n
5
7
4 1
0
0
S
H
P
é
d
i
l
d
i
C
M
E
V
t
e
n
r
e
c
a
e
s
a
e
s
u
x‐
v
/
n
a
2
1
3
0
G
S
M
N
P
F
k
l
k
b
h
i
i
i
O
P
t
r
v
a
n
a
c
6
5
4
5
2
0
1
S
H
P
k
l
k
b
i
i
i
i
d
P
L
t
r
v
a
n
n
e
r
g
7
3
9
5
1
6
2
S
H
P
l
i
i
d
l
è
C
V
n
q
e
e
a
r
e
u
4
0
5
0
2
0
0
S
H
P
ô
l
d
l
d
i
i
H
P
t
p
a
e
a
r
o
v
e
n
c
e
6
5
2
5
3
0
5
h
d
i
T
t
r
p
a
r
y
l
k
l
l
k
i
i
i
i
K
V
P
n
a
m
a
r
4
3
5
5
1
3
5
h
d
i
T
t
r
p
a
r
y
1
i
d
P
S
r
a
m
e
a
m
e
e
y
5
6
1
2
5
1
2
6
h
d
T
i
t
r
p
a
r
y
l
T
t
o
a
8
3
7
'1
1
1
8
'3
2
9
0

1 Affiliatedclinics Pyramide am See and Privatklinik Schwerzenbach

Clinicoperations – national coverage and regional presence

Healthcare real estate – long‐term commitment to clinic operation's growth

Strategy – "Buy, Invest, Reap" on a stable ground

  • Healthcarerealestate
  • • Providestable infrastructure for clinic growth
  • • Continuousdevelopment of clinics and healthcare related buildings
  • • Increaseof operational flexibility due to integrated strategy

Healthcarereal estate development

  • 2006‐2007 Clinique Générale: complete refurbishment
  • 2007 Clinique Valmont: development of parking and terrace
  • 2009 Les Hauts de Genolier: constructionof building
  • 2010 Les Hauts deGenolier: development of parking
  • 2010‐2011 Clinique de Montchoisi: new radiology and underground parking
  • 2011‐2012 Clinique de Genolier: new operating theater, intensive continued care units
  • 2011‐2012 Privatklinik Bethanien: construction of an underground parking, renovation of reception areas and the restaurant, new outdoor terrace and park
  • 2012 Clinica Sant'Anna: newrooms and suites, renovation of reception areas
  • 2013‐2015 Clinica Ars Medica: newbuilding

SelectedAEVIS clinics and healthcare real estate

Clinique de Genolier

Genolier

CantonVaud

Clinique de Genolier – clinic operations

  • 177admitting physicians
  • 290employees
  • 115beds
  • 5operating theatres
  • 2'638surgical interventions
  • Key specialties
  • •Oncology
  • • General anddigestive surgery
  • •Orthopaedics
  • •Gynaecology and Senology (IORT)
  • •Internal medicine
  • • Preventivemedicine
  • • Plasticsurgery
  • Revenue breakdown
  • •Inpatients: 53%
  • •Outpatients: 47%

Clinique de Genolier – healthcare real estate

  • Total site area 57'869m2
  • • Viewover Lake Geneva and the Alps
  • • Roomfor further development
  • Clinique de Genolier
  • •Multi speciality hospital building
  • • Floor area(net): 18'724m2
  • •Floor levels: 7
  • CRG Building
  • • Center withmedical practices and offices
  • • Floor area(net): 4'039m2
  • •Floor levels: 6
  • Les Hauts de Genolier
  • • Medical andassisted living residences
  • • Floor area(net): 10'140m2
  • •Floor levels: 6
  • Genolier Parking
  • •Indoor parking: 109
  • •Outdoor parking: 207

SelectedAEVIS clinics and healthcare real estate

Privatklinik Bethanien

ZurichCantonZurich

PrivatklinikBethanien – clinic operations

  • 223admitting physicians
  • 250employees
  • 96beds
  • 3'775surgical interventions
  • 598deliveries (including Privatklinik Lindberg)
  • Key specialties
  • •Orthopaedics
  • •Gynaecology and obstetrics
  • •Surgery and internal medicine
  • •Visceral surgery
  • •Maxillofacial surgery, ENT
  • • Plastic andaesthetic surgery
  • •Urology
  • Revenue breakdown
    • •Inpatients: 96%
    • •Outpatients: 4%

Privatklinik Bethanien– healthcare real estate

  • Total site area 10'984m2
  • •Ideally located at Zurichberg
  • •Further development possibilities
  • Privatklinik Bethanien
  • •Multi specialty hospital building
  • • Floor area(net): 14'613m2
  • • Totally renovated in 2012 (new entrance and reception areas, underground parking, restaurant withterrace)
  • 2 residential buildings with a direct connection to the clinic
  • • 5apartments
  • • 2medical practices
  • • 42rooms

SelectedAEVIS clinics and healthcare real estate

Clinica Sant'Anna

Lugano CantonTicino

Clinica Sant'Anna – clinicoperations

  • 90admitting physicians
  • 220employees
  • 80beds
  • 4operating theatres
  • 3'900surgical interventions per year
  • 835deliveries
  • Key specialties
  • • Female medicine andsenology
  • •Gynaecology and obstetrics
  • •Neonatology
  • •Oncology
  • •Internal medicine
  • •Specialised surgery
  • • Preventivemedicine
  • Revenue breakdown
  • •Inpatient: 75%
  • •Outpatient: 25%

Clinica Sant'Anna – healthcarereal estate

  • Total site area 22'251m2
  • • Hillsidedevelopment
  • • Viewover Lake Lugano
  • Clinica Sant'Anna
  • •Multi speciality hospital building
  • • Floor area(net): 14'203m2
  • • Floor levels: 8
  • 3 further healthcare real estate on site
  • • Medical relateduse
  • • Floor area(net): 2'953m2
  • Sant'Anna Parking
  • •Indoor parking: 76
  • •Outdoor parking: 112

Other investments – Les Hauts deGenolier

  • Assisted living complex next to Clinique de Genolier
  • 63 luxurious apartments offering modern infrastructure
  • Turnover of CHF 7.9 millionin 2012
  • Multi‐disciplined care team
  • Tailor‐madenursing services
  • Short‐termor long‐term stays

Other investments – Nescens – Added value brand tothe clinics

  • Fruit of a partnership with CSPV‐Centre Suisse de Prévention du Vieillissement SA and La Réserve
  • Leading global anti‐aging specialist "live better andlonger"
  • First brand to bring a comprehensive and evidence‐based answer toprolong healthy life
  • Nescens is ideally positioned as the pioneering brandin this sector
  • Market segment with substantial growth potential, both in Switzerland and abroad
  • Four areas of development
  • • Nescens check‐up centre / preventive medicine at Clinique de Genolier and Clinica Sant'Anna
  • • Nescens better‐aging medspa at La Réserve, Geneva
  • •Anti‐aging cosmeceuticals
  • • Aesthetic medicine andsurgery (Spontini)

Other investments – Clinique Nescens Paris Spontini

  • First clinic of the Group entirely dedicated to aesthetic medicine andsurgery
  • 16tharrondissement of Paris
  • Commercialisedunder the brand Nescens
  • European benchmark in the field of aesthetic medicine andsurgery
  • First quality medical and hotel infrastructure
  • • 20 internationally renowned physicians and surgeons
  • TheClinic opened in December 2012

Other investments – ASAmbulances Services

  • 80% interest in AS Ambulance Services SA, Geneva
  • 80employees
  • Turnover of CHF 7.6 millionin 2012
  • Founder and COO Olivier Gonin owns a 13%stake
  • Acquisitions in line with AEVIS strategy of developing several activities in the healthcaresector
  • Further acquisitions in this sector are planned

Other investments: Swiss AdvancedVision

  • Minority stake of 20% (CHF 2 million investment)
  • First investment inmedical science
  • Swiss Advanced Vision designs, manufactures and distributes a newgeneration of intraocular lenses for cataractsurgery
  • In 2013, Swiss Advanced Vision will produce around 10'000 lenses
  • First revenuesexpected in 2014

Half‐yearly Results 2013: Income Statement

'0
I
C
H
F
0
0
n
1
H
2
0
1
3
1
H
2
0
1
2
R
e
v
e
nu
e
h
wt
g
ro
'8
2
6
2
9
1
1
3
4
%
'8
6
0
3
1
1
E
B
I
T
D
A
in
ma
rg
'6
2
4
9
5
%
1
1.
4
'3
1
5
6
0
%
9.
5
ia
io
d
is
io
De
t
t
t
p
re
c
n
a
n
a
m
o
r
a
n
(
)
'7
1
4
8
4
(
)
'9
9
2
3
E
B
I
T
in
ma
rg
'9
9
1
1
%
4.
6
'4
5
3
7
%
3.
4
in
ia
l
l
F
t
a
nc
re
su
ha
f
lo
f
d
S
i
ty
t
re
o
s
s
o
e
q
u
a
c
c
ou
n
e
(
'1
)
6
1
0
(
'7
)
1
5
4
in
t
ve
s
e
e
s
9
5
(
'0
)
2
5
7
O
d
i
l
t
r
n
a
ry
r
e
s
u
'8
3
6
0
'6
2
6
1
d
l
Ex
in
t
t
ra
o
r
a
ry
re
su
2
8
6
(
)
7
4
5
f
i
b
Ea
t
r
n
ng
s
e
o
r
e
a
x
e
s
'1
6
4
4
8
8
1
In
t
c
o
m
e
ax
e
s
(
)
3
6
(
)
2
2
f
f
h
i
P
t
t
r
o
o
r
e
y
e
a
r
in
ma
rg
'9
2
0
4
2
%
8
9
5
1
%
  • Main growth drivers were clinic acquisitions
  • Organic growth rate was 7.4%. (vs. 3.5%growth for the sector)
  • EBITDAsurged strongly to CHF 24.7m
  • Strong EBIT growth generated by efficiency gains at GSMN and the consolidationof SHP
  • Net profit of CHF 4.9m or CHF 0.33 per share

Half‐yearly Results 2013: Balance Sheet

'0
I
C
H
F
0
0
n
1
H
2
0
1
3
3
1.
1
2.
2
0
1
2
f
ig
b
l
h
K
t
e
y
u
r
e
s
a
a
n
c
e
s
e
e
A
t
s
s
e
s
l
To
t
t
t
a
no
n‐
cu
rre
n
a
s
s
e
s
'8
1
5
6
3
1
'7
1
3
5
6
2
l
To
t
t‐
t
a
cu
rre
n
a
s
s
e
s
'3
6
7
6
0
7
'6
5
9
8
8
6
l
T
t
t
o
a
a
s
s
e
s
'1
8
3
3
3
8
'4
7
3
4
4
8
h
wt
g
ro
1
3
%
i
b
i
l
i
i
L
t
a
e
s
l
i
T
t
t
o
a
e
q
u
y
'0
8
1
7
1
1
'5
6
0
1
1
4
l
l
b
l
To
ia
i
i
ie
t
t
t
a
no
n‐
cu
rre
n
s
'3
3
5
2
1
5
'7
2
6
3
0
3
l
l
b
l
To
ia
i
i
ie
t
t
t
a
cu
rre
n
s
'7
3
0
9
4
2
'2
3
0
9
0
5
l
l
i
b
i
l
i
i
T
t
t
o
a
a
e
s
'0
6
6
2
5
7
'9
5
7
2
0
8
l
i
d
l
i
b
i
l
i
i
T
t
t
t
o
a
e
q
u
y
a
n
a
e
s
'1
8
3
3
3
8
'4
7
3
4
4
8
h
wt
g
ro
1
3
%
  • Real estate represents approx. 55% of totalassets
  • Equity ratio at 20.5%
  • LTVratio at 50.7%
  • AEVIS has chosen to offset all goodwill on the balance sheet with shareholder's equity (i.e. no goodwill onthe balance sheet)
  • With an alternative goodwill accounting approach (capitalised goodwill), economic equity ratio wouldhave been at around 29%

AEVIS– outlook 2013

Revenue forecast 2013 of more than CHF 450mwith the current perimeter

  • • Newacquisitions already realised in 2013 (Valère, Providence, Villa im Park and Schmerzklinik)
  • •Internal growth (constant recruitment of new physicians)
  • Revenue forecast 2014 of more than CHF 500m
  • • Withacquisitions fully consolidated
  • AEVIS will focus on continuing the growth strategy of GSMN and evaluate further opportunities in the healthcare related real estate market
  • AEVIS plans to invest in complementary activities supporting its overall strategy
  • •Outpatient Medical Centers (ambulatory surgery, radiology, dental clinics,…)
  • •Medical residences
  • • Hotel or hotel‐relatedactivities.
  • • Lifesciences, Innovation & Research
  • • Services topeople
  • In the mid‐term AEVIS expects to realise an EBITDA margin of more than 20%, in line with the industry benchmark
  • •Further optimisation of the existing facilities
  • •Objective of 2 to 4% annual EBITDA improvement
  • AEVIS foresees tobe able to reinforce it's distribution policy in 2013

Investmenthighlights

i
A
t
t
t
r
a
c
v
e
f
t
s
e
c
o
r
o
c
u
s
h
f
h
d
l
h
l
h
i
i
i
i
i
i
H
t
t
t
t
t
t
t

g
a
r
a
c
v
e
n
e
s
s
o
e
g
r
o
w
n
g
a
n
r
e
c
e
s
s
o
n
‐r
e
s
e
n
e
a
c
a
r
e
s
e
c
o
r
(
)
h
d
l
l
d
D
i
t
t
e
m
o
g
r
a
p
c
r
e
n
s
m
o
r
e
p
e
o
p
e
g
e
o
e
r

l
h
(
l
h
)
i
i
I
t
n
c
r
e
a
s
n
g
e
c
o
n
o
m
c
w
e
a
p
e
o
p
e
a
v
e
m
o
r
e
m
o
n
e
y

f
(
)
l
l
h
l
h
l
I
i
i
i
i
t
t
n
c
r
e
a
s
n
g
n
g
n
e
s
s
o
p
a
o
r
e
a
c
a
r
e
s
e
r
c
e
s
p
e
o
p
e
p
a
m
o
r
e
w
y
v
y
k
M
t
a
r
e
i
i
i
t
p
o
s
o
n
n
g
d
l
l
h
b
d
h
l
S
S
i
i
i
i
i
i
t
t
t

e
c
o
n
a
r
g
e
s
w
s
s
p
r
v
a
e
c
n
c
s
g
r
o
u
p
w
r
o
a
g
e
o
g
r
a
p
c
a
p
r
e
s
e
n
c
e
à‐
h
l
h
d
h
S
i
i
i
i
i
i
S
i
i
i
i
t
t
t
t
t
t
t
r
o
n
g
n
e
g
o
a
o
n
p
o
s
o
n
v
s‐
v
s
w
s
s
e
a
c
a
r
e
n
s
u
r
e
r
s
a
n
a
u
o
r
e
s

f
d
l
l
d
l
l
h
k
l
d
I
i
i
i
i
i
i
t
t
t
t
t
t
t
e
a
p
o
s
o
n
e
o
p
a
a
c
e
r
o
e
n
e
r
e
m
a
r
e
c
o
n
s
o
a
o
n
y
y
v
u
u

h
d
f
l
h
h
l
C
i
i
i
i
t
t
t
t
o
p
e
w
a
n
n
u
e
n
c
e
e
c
a
n
g
n
g
r
e
g
u
a
o
r
y
e
n
v
r
o
n
m
e
n
d
I
t
t
n
e
g
r
a
e
b
i
u
s
n
e
s
s
d
l
m
o
e
d
b
l
h
d
d
l
d
i
i
i
i
i
S
t
t
t
t
t
t
t

r
o
n
g
a
n
s
a
e
c
a
s
g
e
n
e
r
a
o
n
u
e
o
n
e
g
r
a
e
c
n
c
o
p
e
r
a
o
n
s
a
n
h
l
h
l
t
t
t
e
a
c
a
r
e
r
e
a
e
s
a
e
f
f
f
h
l
b
l
d
l
d
l
H
i
i
i
i
j
i
i
t
t
t
t
t
t

g
e
o
r
o
n
e
e
o
p
m
e
n
o
o
p
e
r
a
o
n
s
a
n
r
e
a
e
s
a
e
x
y
v
L
t
o
n
e
r
m
g

b
l
i
i
t
t
s
a
y
h
b
l
f
h
f
l
d
l
d
b
H
i
i
i
i
i
i
i
t
t
t
t

g
v
s
y
o
c
a
s
o
w
s
u
e
o
r
e
g
u
a
e
u
s
n
e
s
s
e
n
v
r
o
n
m
e
n
b
l
h
f
l
l
h
k
l
l
S
i
i
i
i
i
t
t
t
t
t

a
y
n
c
a
s
o
w
p
a
n
n
n
g
a
n
s
o
o
w
o
p
e
r
a
n
g
e
v
e
r
a
g
e
f
l
h
l
h
h
A
E
V
I
S
i
E
B
I
T
D
A
i
2
0
%
i
i
i
t
t
t
t
t

e
p
e
c
s
o
r
e
a
s
e
a
n
m
a
r
g
n
o
m
o
r
e
a
n
n
n
e
e
x
w
,
d
b
h
k
i
t
n
u
s
r
y
e
n
c
m
a
r

FinancialCalendar

November 2013 Publication of 3Q2013 Turnover February 2014 Publication of FY2013 Turnover 30 April 2014 Publication of Annual Result 2013 May 2014 Publication of 1Q2014 Turnover 4 June 2014 Ordinary General Shareholders Meeting for the year 2013 30September 2014 Publication Half Year Results 1H2014

AEVIS Holding SA c/o Clinique Générale Ste‐Anne rue Hans‐Geiler 61700 Fribourg Tel. +41 26 350 02 02 Fax +4126 350 02 03

Media & Investor Relations c/o Dynamics Group Edwin van der Geest / Philippe Blangey Tel. +41 43 268 32 32 Fax +41 43 268 32 39 [email protected]

Disclaimer

This communication contains statements that constitute "forward‐looking statements". In this communication, such forward‐looking statements include, without limitation, statements relating to our financial condition, results of operations and business and certain of our strategic plans and objectives. Because these forward‐looking statements are subject to risks and uncertainties, actual future results may differ materially from those expressed in or implied by the statements. Many of these risks and uncertainties relate to factors which are beyond AEVIS Holding's ability to control or estimate precisely, such as future market conditions, currency fluctuations, the behavior of other market participants, the actions of governmental regulators and other risk factors detailed in AEVIS Holding's past and future filings and reports and in past and future filings, press releases, reports and other information posted on AEVIS Group companies websites. Readers are cautioned not to put undue reliance on forward‐looking statements, which speak only of the date of this communication. AEVIS Holding disclaims any intention or obligation to update and revise any forward‐looking statements, whether as a result of new information, future eventsor otherwise.

Talk to a Data Expert

Have a question? We'll get back to you promptly.